Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 7—July 2010

Letter

Mycobacterium conceptionense Infection after Breast Implant Surgery, France

Sandrine Thibeaut, Pierre-Yves Levy, Marie-Laure Pelletier, and Michel DrancourtComments to Author 
Author affiliations: Université de la Méditerranée, Marseille, France (S. Thibeaut, P.-Y. Levy, M. Drancourt); Clinique la Casamance, Aubagne, France (P.-Y. Levy, M.-L. Pelletier)

Main Article

Table

Three cases of Mycobacterium conceptionense infection in female patients*

Patient age, y Clinical situation Identification Treatment
Reference
Nature Duration, mo
31 Posttraumatic osteitis 16S rRNA, soda, hsp65, recA, rpoB Antimicrobial drug therapy: AMC 3 (4)
43 Subcutaneous abscess without trauma partial 1,464-bp 16S rRNA gene‡ Surgery and antimicrobial drug therapy: COT and CLA; then DOX and CLA; then LIN and CLA 5 (10)
58 Breast implant infection rpo Surgery and antimicrobial drug therapy: CIP and AZY; then CIP, AZY, and DOX; then DOX 18 This report

*AMC, amoxicillin/clavulanic acid; COT, cotrimoxazole; CLA, clarithromycin; DOX, doxycycline; LIN, linezolid; CIP, ciprofloxacin, AZY, azythromycin. The outcome for all 3 patients was favorable.
†GenBank accession nos.: 16S rRNA, AY859684; rpoB, AY859695; hsp65, AY859678; sodA, AY859708; recA, AY859690.
‡GenBank accession no. AM884289.1.
§GenBank accession no. AY859695.1.

Main Article

TOP